Italian healthcare resource consumptions and direct costs of adults with atopic dermatitis before and after dupilumab treatment-Reference-Cited by-同舟云学术

Italian healthcare resource consumptions and direct costs of adults with atopic dermatitis before and after dupilumab treatment

Published:2024-07 Issue:4 Volume:159 Page:
ISSN:2784-8671
Container-title:Italian Journal of Dermatology and Venereology
language:
Short-container-title:Ital J Dermatol Venereol

Author:

RONCONI Giulia,DONDI Letizia,CALABRIA Silvia,DONDI Leonardo,PEDRINI Antonella,ESPOSITO Immacolata,SCATTAREGGIA Maria,ROGLIANI Paola,TRIMARCHI Matteo,COSTANZO Antonio,PATRUNO Cataldo,NALDI Luigi,MARTINI Nello

Publisher

Edizioni Minerva Medica

Link

https://www.minervamedica.it/pdf.php?cod=R23Y2024N04A0417

Reference32 articles.

1. Patient Journey in Atopic Dermatitis: The Real-World Scenario;Carrascosa JM;Dermatol Ther (Heidelb),2021

2. Burden of Moderate to Severe Atopic Dermatitis in Adults from France, Italy, and the UK: Patient-Reported Outcomes and Treatment Patterns;Kleyn CE;Dermatol Ther (Heidelb),2022

3. Long-term management of moderate-to-severe adult atopic dermatitis: a consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Association of Italian Territorial and Hospital Allergists and Immunologists (AAIITO), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA), and the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC);Costanzo A;Ital J Dermatol Venereol,2022

4. Atopic Dermatitis: Clinical Aspects and Unmet Needs;Lobefaro F;Biomedicines,2022

5. Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review;Iannone M;Curr Med Res Opin,2021